论文信息 - Circulating tumor DNA as a novel prognostic indicator - 字舞流文

Circulating tumor DNA as a novel prognostic indicator

J. Tabernero | A. Vivancos

[1] B. Gyawali. PSY2-1 From Nepal to Nippon to the North , 2022, Annals of Oncology.

[2] David R. Jones,et al. Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer , 2021, Nature Medicine.

[3] J. Fletcher,et al. Clinical value of next generation sequencing of plasma cell-free DNA in gastrointestinal stromal tumors , 2020, BMC Cancer.

[4] T. Peretz,et al. Life and death of circulating cell-free DNA , 2019, Cancer biology & therapy.

[5] P. V. Van Schil,et al. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[6] Benjamin Solomon,et al. Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology , 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[7] Ashwini Naik,et al. Phylogenetic ctDNA analysis depicts early stage lung cancer evolution , 2017, Nature.

[8] M. Choti,et al. Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies , 2014, Science Translational Medicine.